IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.1630
+0.0056 (3.56%)
At close: May 12, 2025, 4:00 PM
0.1626
-0.0004 (-0.25%)
After-hours: May 12, 2025, 7:20 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $13.25 million as of May 12, 2025. Its market cap has decreased by -71.13% in one year.
Market Cap
13.25M
Enterprise Value
5.63M
1-Year Change
-71.13%
Ranking
Category
Stock Price
$0.16
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $13.25M, a decrease of -92.94%. That is a compound annual growth rate of -50.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 12.79M | -31.39% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |